The action of a gene called ATDC is required for the development of pancreatic cancer, a new study finds.
The work builds on the theory that many cancers arise when adult cells—to resupply cells lost to injury and inflammation—switch back into more “primitive,” high-growth cell types, like those that drive fetal development.
When this reversion happens in the presence of other genetic mistakes, a repair process meant to start and stop quickly continues unchecked.
New details of this cancer-causing switch to primitive cells, and of the role of ATDC in pancreatic cancer formation, are revealed in a study of mice and human patient samples published online May 2 in the journal Genes & Development.
Led by researchers from NYU School of Medicine and the University of Michigan—Ann Arbor, the study found that ATDC must be active if pancreatic cells, when injured, are to reacquire primitive stem-cell qualities and undergo the early steps that lead to the development of pancreatic cancer.
“We found that deleting the ATDC gene in pancreatic cells resulted in one of the most profound blocks of tumor formation ever observed in a well-known mice model engineered to develop pancreatic ductal adenocarcinoma, or PDA, which faithfully mimics the human disease,” says corresponding author Diane Simeone, MD, director of the Pancreatic Cancer Center of NYU Langone Health’s Perlmutter Cancer Center. “We thought the deletion would slow cancer growth, not completely prevent it.”
The search for better treatment in these cases is especially urgent, says Dr. Simeone, given that PDA has the worst prognosis of any major malignancy and is on track to become the second leading cause of cancer-related death by 2030.
Healing Gone Awry
The study focused on acinar cells in the pancreas that secrete digestive enzymes through a network of partnering ducts into the small intestine. These same digestive enzymes can subject this tissue to low levels of damage. In response, acinar cells have evolved to readily switch back into stem cell types that resemble their high-growth ancestors, a feature that they share with pancreatic duct cells.
This ability to regenerate comes at a price, researchers say, because such cells are prone to become cancerous when they also acquire random DNA changes, including those in the gene KRAS that are known to drive aggressive growth in more than 90 percent of pancreatic cancers.
Specifically, stressed acinar cells are known to temporarily undergo acinar-to-ductal metaplasia, or ADM, a step toward a primitive cell type, to resupply cells. This sets the stage for a second shift into pancreatic intraepithelial neoplasia, or PanIN, in which cells no longer multiply under normal controls.
In the current study, the researchers found that mutant KRAS and other genetic abnormalities induced aggressive pancreatic cancer in 100 percent of study mice when the ATDC gene was present and active, but in none of the same cancer-prone mice lacking the gene. Neither did acinar cells in the ATDC “knock-out” mice undergo ADM or transformation to PanIN.
To get a better look at the early steps in pancreatic cancer formation, the research team artificially caused pancreatitis in mice by treating them with cerulein, a signaling protein fragment that damages pancreatic tissue. ATDC gene expression did not increase right after the damage, but did so a few days later and in line with the timeframe required for acinar cells to reprogram genetically into their ductal cell forebears.
Further experiments confirmed that the expression of ATDC triggers beta-catenin, a cell-signaling protein that, upon receiving the right trigger, activates genes including SOX9. Earlier studies linked SOX9 to the development of ductal stem cells and to the aggressive growth seen in PDA. Consistent with this work, the current study found that the inability of cells lacking ATDCto become cancerous was due to their inability to induce SOX9 expression.
The authors also examined ATDC expression in ADM lesions from 12 samples of human pancreatic tissue. The team found it to be more active in human ADM lesions along with beta-catenin and SOX9, and its activation increased further during the transition of ADM into human pancreatic ductal adenocarcinoma.
The findings, says Dr. Simeone, identify ATDC, beta-catenin, SOX9, and their signaling partners as potential targets in the design of new treatment approaches and prevention strategies for pancreatic cancer.
The Latest on: Pancreatic cancer
via Google News
The Latest on: Pancreatic cancer
- New drug combo may improve pancreatic cancer therapyon November 18, 2019 at 3:26 pm
A new study by scientists at Sanford Burnham Prebys Medical Discovery Institute have discovered a combination of two cancer-fighting drugs that successfully worked on pancreatic tumor in mice, ...
- Mouse study prompts clinical trial of new pancreatic cancer therapyon November 18, 2019 at 1:11 pm
They are meeting with oncologists at Oregon Health and Science University to plan the trial. A cancer researcher not involved in the study said its findings make a clinical trial worth performing in ...
- Pancreatic cancer survivor from Berks offers hope to others diagnosed with the diseaseon November 18, 2019 at 12:21 pm
From there he went to a gastroenterologist, who gave him a startling diagnosis. The Ruscombmanor Township man had pancreatic cancer, the third-leading cause of death from cancer in the United States, ...
- One-two punch drug combination offers hope for pancreatic cancer therapyon November 18, 2019 at 8:03 am
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a combination of two anti-cancer compounds that shrank pancreatic tumors in mice—supporting the immediate evaluation of ...
- David Gibson, owner of Gibson’s Bakery in Oberlin, dies after fight with pancreatic canceron November 17, 2019 at 12:36 pm
OBERLIN, Ohio – David Gibson, the owner of Gibson’s Bakery of Oberlin, died Saturday at his home after a months-long fight with pancreatic cancer. The news of his death was shared on the family ...
- David Gibson of Oberlin's Gibson's Bakery passes away after battle with pancreatic canceron November 16, 2019 at 3:02 pm
Gibson's Bakery announced on its Facebook page that David Gibson died on Saturday morning at home after a battle with pancreatic cancer. In June of this year, David Gibson, his son Allyn Gibson, and ...
- November is Pancreatic Cancer Awareness Monthon November 14, 2019 at 4:04 pm
NOVEMBER IS PANCREATIC CANCER AWARENESS MONTH. AND OUR LOCAL PANCREATIC CANCER ACTION NETWORK HAS SEVERAL EVENTS PLANNED. I’M JOINED NOW BY HOLLY IGNATOWSKI AND SURVIVOR TIM NENNIG. THANK YOU FOR ...
- 'Jeopardy!' contestants ask fans to play along for pancreatic cancer researchon November 14, 2019 at 2:30 pm
Jeopardy!' contestants ask fans to play along for pancreatic cancer research In honor of Alex Trebek and Larry Martin, "Jeopardy!" contestants are asking fans to play along this week and donate to ...
- Farm to Table dinner raises funds for Aiken's pancreatic cancer patientson November 14, 2019 at 2:26 pm
Farm to Table is a bustling event that grows larger every year and serves as one of the biggest fundraisers for pancreatic cancer patients in Aiken County; however, the event – which packed Newberry ...
- First Texas 5k walk to raise funds for pancreatic cancer set for Woodlands on Saturdayon November 14, 2019 at 12:54 pm
June 2019 United in Purple 5k walk in Lake Tye in Monroe, WA. June 2019 The first United in Purple 5k walk in Texas for pancreatic cancer is set for Creekside Park in The Woodlands on Saturday. After ...
via Bing News